Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions

Abstract

Nucleophosmin (NPM)-1 is a multifunctional protein involved in a variety of biologic processes and has been implicated in the pathogenesis of several human malignancies. To gain insight into the role of isolated fragments in NPM1 activities, we dissected the C-terminal domain (CTD) into its helical fragments. In this study, we observed the unexpected structural behavior of the peptide fragment corresponding to helix (H)2 (residues 264-277). This peptide has a strong tendency to form amyloidlike assemblies endowed with fibrillar morphology and β-sheet structure, under physiologic conditions, as shown by circular dichroism, thioflavin T, and Congo red binding assays; dynamic light scattering; and atomic force microscopy. The aggregates are also toxic to neuroblastoma cells, as determined using 3-(4;5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction and Ca(2+) influx assays. We also found that the extension of the H2 sequence beyond its N terminus, comprising the connecting loop with H1, delayed aggregation and its associated cytotoxicity, suggesting that contiguous regions of H2 have a protective role in preventing aggregation. Our findings and those in the literature suggest that the helical structures present in the CTD are important in preventing harmful aggregation. These findings could elucidate the pathogenesis of acute myeloid leukemia (AML) caused by NPM1 mutants. Because the CTD is not properly folded in these mutants, we hypothesize that the aggregation propensity of this NPM1 region is involved in the pathogenesis of AML. Preliminary assays on NPM1-Cter-MutA, the most frequent AML-CTD mutation, revealed its significant propensity for aggregation. Thus, the aggregation phenomena should be seriously considered in studies aimed at unveiling the molecular mechanisms of this pathology.

Chromosomal passenger complex hydrodynamics suggests chaperoning of the inactive state by nucleoplasmin/nucleophosmin

“…, 2016). NPM1 protects a number of different proteins from aggregation during thermal denaturation (Szebeni and Olson, 1999), despite having amyloid-like assembly properties itself (Di Natale et al. , 2015; Russo et al.…”

Molecules that target nucleophosmin for cancer treatment: an update

“…These cytosolic activities promote leukemic blasts survival and may also counteract the nucleolar stress caused by NPM1 delocalization. Additionally, the unfolded C-terminal domain of NPM1c+ has been recently shown to contain amyloidogenic regions that may also contribute to the gain of cytosolic functions played by the protein [81]. …”

Molecular signaling involving intrinsically disordered proteins in prostate cancer

“…Notably, NPM1 has been identified as the most frequently mutated gene in acute myeloid leukemia (AML) patients, accounting for approximately 30% of cases 146. Besides its primary role as a therapeutic target in AML drug discovery programs, it represents an important model for multidomain proteins 2539147. AR and NPM1 interact in vitro and in vivo , and NPM1 is critical for androgen-dependent transcriptional activation in LNCaP cells as an anti-NPM, siRNA downregulates transcription of a transfected ARE-containing reporter promoter as well as expression of the endogenous androgen-responsive PSA gene.…”

“…The misfolding of many proteins is often accompanied with protein aggregation causing several human diseases that originate from the deposition of protein aggregates formed from specific proteins or protein fragments, which accumulate in a variety of organs and tissues 293031323334353637. In contrast, several diseases are caused by misfolding and, therefore, dysfunctional proteins 173839…”